Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04880772
What this trial is testing

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery

Who this might be right for
Cancer of ColonCancer of RectumLiver Metastases
East Lancashire Hospitals NHS Trust 42
Testing effectiveness (Phase 2)Study completedNCT01575730
What this trial is testing

Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis

Who this might be right for
Peritoneal Carcinomatosis
University Hospital, Ghent 45
Testing effectiveness (Phase 2)UnknownNCT05551247
What this trial is testing

Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 30
Large-scale testing (Phase 3)Study completedNCT00004252
What this trial is testing

Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Pfizer
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714447
What this trial is testing

Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer

Who this might be right for
CRC (Colorectal Cancer)BRAF
Sun Yat-sen University 91
Early research (Phase 1)Active Not RecruitingNCT02817633
What this trial is testing

TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Who this might be right for
Neoplasms
Tesaro, Inc. 463
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07358585
What this trial is testing

A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer Adenocarcinoma
Shanghai Henlius Biotech 126
Testing effectiveness (Phase 2)Study completedNCT01281761
What this trial is testing

Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)

Who this might be right for
Metastatic Colorectal Cancer
Samsung Medical Center 52
Not applicableStudy completedNCT01959269
What this trial is testing

Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy

Who this might be right for
Colorectal Neoplasm
Bayer 483
Not applicableStudy completedNCT06137170
What this trial is testing

A Real-World Study to Learn More About the Order of Different Treatments and Their Effects in People With Metastatic Colorectal Cancer Receiving Their Third and Fourth Line of Treatment

Who this might be right for
Metastatic Colorectal Cancer
Bayer 121
Large-scale testing (Phase 3)Looking for participantsNCT06185556
What this trial is testing

COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases

Who this might be right for
Colorectal CancerLiver MetastasesLiver Metastasis Colon Cancer+1 more
Amsterdam UMC, location VUmc 78
Testing effectiveness (Phase 2)Ended earlyNCT04844073
What this trial is testing

TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Who this might be right for
Squamous Cell Cancer of Head and Neck (SCCHN)Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer
Takeda 95
Testing effectiveness (Phase 2)Study completedNCT00205322
What this trial is testing

Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University of Wisconsin, Madison 45
Testing effectiveness (Phase 2)Study completedNCT03698461
What this trial is testing

Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab

Who this might be right for
Colorectal NeoplasmsNeoplasm MetastasisColonic Neoplasms+1 more
Asan Medical Center 20
Large-scale testing (Phase 3)Study completedNCT00154102
What this trial is testing

Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)

Who this might be right for
Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer
Merck KGaA, Darmstadt, Germany 1,221
Testing effectiveness (Phase 2)Study completedNCT00111761
What this trial is testing

Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Amgen 43
Early research (Phase 1)Study completedNCT02416466
What this trial is testing

CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases

Who this might be right for
Liver Metastases
Roger Williams Medical Center 8
Not applicableUnknownNCT03956641
What this trial is testing

Evolution of the Physical Condition in Treated Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer MetastaticBreast Cancer FemaleColon Cancer
Centre Paul Strauss 300
Large-scale testing (Phase 3)UnknownNCT04233151
What this trial is testing

QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 590
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Next Page